论文部分内容阅读
目的 :探讨化疗、放疗与手术联合治疗晚期上颌窦癌的可行性。方法 :术前放疗和手术 61例 ,术前化疗和手术 60例。放疗采用直线加速器和 (或 ) 60 Co,剂量为 40～ 60 Gy。化疗采用 DOP(顺氯氨铂加长春新碱加平阳霉素 )方案。结果 :放疗和手术组 3年和 5年生存率分别为 36.1 %和31 .1 % ;化疗和手术组分别为 35%和 30 %。结论 :术前化疗加手术是治疗晚期上颌窦癌的可行性方法 ,且化疗能反复应用 ,提高手术效果。
Objective: To investigate the feasibility of combined chemotherapy, radiotherapy and surgery in the treatment of advanced maxillary sinus cancer. Methods: Preoperative radiotherapy and surgery in 61 cases, preoperative chemotherapy and surgery in 60 cases. Radiotherapy using a linear accelerator and / or 60 Co, a dose of 40 ~ 60 Gy. Chemotherapy with DOP (cisplatin plus vincristine plus pingyangmycin) program. Results: The 3-year and 5-year survival rates of radiotherapy and surgery group were 36.1% and 31.1% respectively, while those of chemotherapy and surgery group were 35% and 30% respectively. Conclusion: Preoperative chemotherapy plus surgery is a feasible method for the treatment of advanced maxillary sinus cancer, and chemotherapy can be repeatedly applied to improve the surgical results.